PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 172 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $12,568,000 | -75.8% | 255,700 | -84.2% | 0.16% | -71.9% |
Q2 2018 | $52,007,000 | -18.1% | 1,622,684 | -20.4% | 0.59% | -14.9% |
Q1 2018 | $63,488,000 | +16.8% | 2,038,153 | +71.1% | 0.69% | +30.9% |
Q4 2017 | $54,369,000 | +27.2% | 1,191,007 | +4.7% | 0.53% | +45.5% |
Q3 2017 | $42,728,000 | +56.7% | 1,137,900 | +99.1% | 0.36% | +22.6% |
Q2 2017 | $27,261,000 | -50.4% | 571,500 | -52.6% | 0.30% | -48.3% |
Q1 2017 | $54,989,000 | +101.7% | 1,205,900 | +42.9% | 0.57% | +46.2% |
Q4 2016 | $27,261,000 | +95.0% | 844,000 | +106.6% | 0.39% | +172.2% |
Q3 2016 | $13,979,000 | -30.9% | 408,500 | -31.9% | 0.14% | -65.5% |
Q2 2016 | $20,238,000 | +38.9% | 600,000 | +118.2% | 0.42% | +6.1% |
Q1 2016 | $14,570,000 | -31.0% | 275,000 | 0.0% | 0.39% | -26.8% |
Q4 2015 | $21,117,000 | +46.8% | 275,000 | -21.4% | 0.54% | +33.6% |
Q3 2015 | $14,385,000 | -37.4% | 350,000 | +7.7% | 0.40% | +49.4% |
Q2 2015 | $22,984,000 | +12.5% | 325,000 | +41.3% | 0.27% | -2.5% |
Q1 2015 | $20,436,000 | – | 230,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |